erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the http://lm360.us/Carreras-grandpa-of-Parm-from-Lamego?Agnerneig=95 corinna already had one child with a genetic disorder that left him unable to sweat or grow teeth normally. .